Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 16;99(15):1156-1161.
doi: 10.3760/cma.j.issn.0376-2491.2019.15.008.

[Effect of apolipoprotein E genotype on magnetic resonance spectrum in amnestic mild cognitive impairment and Alzheimer's disease patients]

[Article in Chinese]
Affiliations

[Effect of apolipoprotein E genotype on magnetic resonance spectrum in amnestic mild cognitive impairment and Alzheimer's disease patients]

[Article in Chinese]
X Q Zhu et al. Zhonghua Yi Xue Za Zhi. .

Abstract

Objective: To explore the relationship between apolipoprotein E (ApoE) gene polymorphism and hydrogen proton magnetic resonance spectroscopy ((1)H-MRS) in patients with Alzheimer's disease (AD) and amnestic mild cognitive impairment(aMCI). Methods: The cognitive function of 35 AD patients (AD group), 35 aMCI patients (aMCI group) and 36 normal controls (NC group) were evaluated by neuropsychological scales, including Mini-mental State Examination (MMSE) and Cambridge Cognitive Examination-Chinese version (CAMCOG-C). The genotypes of ApoE were analyzed by high-resolution melting assay. Brain regional metabolites were measured via (1)H-MRS technique with the regions of interest (ROIs) located in the left frontal lobe and left hippocampus. Results: The CAMCOG-C (NC group 94.00 (8.50);aMCI group 86.00(8.00);AD group 61.00(18.0)) and MMSE (NC group 29.00 (2.00);aMCI group 26.00(2.00);AD group 13.00(9.5)) scores in AD and aMCI group were significantly lower in comparison with that in NC group (P<0.05). There was multi-domain cognitive impairment both in AD and aMCI. The CAMCOG-C (ε4 carriers 76.00(28.00);no-ε4 carriers 89.00 (17.00)) and MMSE (ε4 carriers 23.00(16.00);no-ε4 carriers (27.00 (6.00))scores in ε4 carriers were significantly lower than those in no-ε4 carriers (P<0.05). The AD and aMCI groups showed decreased NAA/Cr ratio in the left hippocampus as well as elevated Cho/Cr ratio and MI/Cr in the left frontal lobe compared to the NC group (P<0.05). This change was even more pronounced in AD group when compared to aMCI group. The NAA/Cr ratio and Cho/Cr ratio in the left hippocampus in ε4 carriers were lower, the MI/Cr ratio in left frontal lobe in ε4 carriers was higher (P<0.05). Conclusions: ApoE gene polymorphism affects the alteration of (1)H-MRS in AD and aMCI patients. The combination of ApoE gene polymorphism and (1)H-MRS may be more useful to differentiate and diagnose AD and aMCI early.

目的: 探讨载脂蛋白E(ApoE)基因型对遗忘型轻度认知障碍(aMCI)和阿尔茨海默病(AD)患者氢质子磁共振波谱((1)H-MRS)的影响。 方法: 选取2016年1月至2018年1月就诊于安徽医科大学第一附属医院神经内科的35例AD患者(AD组),35例aMCI患者(aMCI组)和36名性别和年龄相匹配的认知正常者(对照组,NC组)为研究对象,采用简易智能状态量表(MMSE)、剑桥老年认知检查表中国修订版(CAMCOG-C)等多种神经心理学量表对所有受试对象进行认知功能评价;采用高分辨率熔解曲线法分析ApoE基因型;利用(1)H-MRS技术,计算左侧海马和左侧额叶的N-乙酰天冬氨酸/肌酸(NAA/Cr)、胆碱/肌酸(Cho/Cr)、肌醇/肌酸(MI/Cr)的比值。 结果: AD组和aMCI组MMSE评分[NC组29.00(2.00)分、aMCI组26.00(2.00)分、AD组13.00(9.50)分]、CAMCOG-C总分[NC组94.00 (8.50)分、aMCI组86.00(8.00)分、AD组61.00(18.0)分]及其亚分包括定向、语言、记忆、执行、计算、思维、知觉等子项目评分均显著低于对照组,差异均有统计学意义(均P<0.05)。AD和aMCI组中ε4等位基因携带率均显著高于对照组,且AD组中ApoE ε4等位基因携带率较aMCI组更高(均P<0.05)。ApoE ε4等位基因携带者MMSE评分[ApoE ε4等位基因携带者23.00(16.00)分、非携带者27.00 (6.00)分]及CAMCOG-C评分[ApoE ε4等位基因携带者76.00(28.00)分、非携带者89.00(17.00)分]均显著低于非携带者(均P<0.05)。MRS结果中,AD组和aMCI组左侧海马NAA/Cr比值均显著低于对照组,且AD组左侧海马NAA/Cr比值显著低于aMCI组;AD组和aMCI组左侧额叶Cho/Cr比值和MI/Cr比值显著高于对照组,且以AD组升高较aMCI更为明显(均P<0.05);ApoE ε4等位基因携带者左侧海马NAA/Cr和Cho/Cr比值均显著低于非携带者组,左侧额叶MI/Cr比值显著高于非携带者组(均P<0.05)。 结论: ApoE等位基因影响aMCI和AD患者MRS改变,联合ApoE基因型和MRS检测对AD及aMCI早期诊断及评估具有一定的临床价值。.

Keywords: Alzheimer′s disease; Apolipoprotein E; Hydrogen proton magnetic resonance spectroscopy; Mild cognitive impairment.

PubMed Disclaimer

Similar articles

Cited by

Substances